John DeLuca Selected Research

John DeLuca Research Topics

21	Multiple Sclerosis 05/2024 - 02/2009
14	Cognitive Dysfunction 10/2023 - 08/2003
5	Fatigue 10/2023 - 06/2008
3	Atrophy 10/2022 - 02/2013
3	Brain Injuries (Brain Injury) 01/2022 - 06/2002
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 03/2008
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 01/2015
2	COVID-19 12/2022 - 01/2022
2	Nervous System Diseases (Neurological Disorders) 01/2017 - 01/2015
1	Dizziness (Lightheadedness) 10/2023
1	Relapsing-Remitting Multiple Sclerosis 10/2023
1	Headache (Headaches) 10/2023
1	Pain (Aches) 10/2023
1	Inflammation (Inflammations) 01/2022
1	Chronic Progressive Multiple Sclerosis 01/2022
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2015
1	Neoplasms (Cancer) 01/2015
1	Colonic Neoplasms (Colon Cancer) 03/2014
1	Bacteremia 03/2014
1	Carcinoma (Carcinomatosis) 03/2014
1	Neutropenia 06/2008
1	Hyperglycemia 06/2008
1	Lymphopenia (Lymphocytopenia) 06/2008
1	Dyspnea (Shortness of Breath) 06/2008

3	Biomarkers (Surrogate Marker)IBA 10/2022 - 02/2013
2	salicylhydroxamic acid (SHAM)IBA 10/2023 - 05/2020
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2022 - 02/2021
1	Alemtuzumab (Campath)FDA Link 05/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2022
1	siponimodIBA 01/2022
1	ozanimodIBA 02/2021
1	InterferonsIBA 02/2021
1	SteroidsIBA 01/2017
1	propylene diquat (PDQ(+))IBA 07/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016
1	dactolisibIBA 01/2016
1	Dopamine (Intropin)FDA LinkGeneric 01/2015
1	Hemoglobins (Hemoglobin)IBA 06/2008
1	Lenalidomide (CC 5013)FDA Link 06/2008
1	Interferon-alpha (Interferon Alfa)IBA 03/2008
1	Antidepressive Agents (Antidepressants)IBA 08/2003

13	Cognitive Training 05/2024 - 01/2015
6	Therapeutics 04/2022 - 06/2013
4	Activities of Daily Living (ADL) 01/2023 - 02/2009
1	Exoskeleton Device 06/2021
1	Exercise Therapy (Therapy, Exercise) 06/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Resistance Training 01/2020
1	Length of Stay 01/2020
1	Lymph Node Excision (Lymph Node Dissection) 03/2014
1	Cholecystectomy 03/2014
1	Telerehabilitation 06/2002